Nasdaq · CIK 0001689548
PRAX Praxis Precision Medicines, Inc.
Insider trading from SEC Form 4. Last filing Nov 19, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
3
with a Form 4 at this company
Signals
Open-market buys and sells at Praxis Precision Medicines, Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 34Weak | sell 2 | Mastrocola Lauren Principal Accounting Officer | $424k | 5,188 | -48% | - | |
| 38Weak | sell 2 | Nemiroff Alex General Counsel and Secretary | $661k | 8,239 | -44% | - |
Congressional trades
1 trade in PRAX disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | PRAX Praxis Precision Medicines, Inc. - Common Stock | $1,001 to $15k | Jul 30, 2026 | 36 days after the trade |
Transactions
The last 8 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | Kelly Timothy Edwin Chief Financial Officer | AGrant or award Common Stock | +205 | $37.40 | $7,667 | 12,345 | Nov 19, 2024 |
| Nov 14, 2024 | Mastrocola Lauren Principal Accounting Officer | AGrant or award Common Stock | +294 | $37.40 | $11k | 5,907 | Nov 19, 2024 |
| Nov 14, 2024 | Mastrocola Lauren Principal Accounting Officer | MOption exercise Common Stock | +4,374 | $56.94 | $249k | 10,801 | Nov 15, 2024 |
| Nov 14, 2024 | Nemiroff Alex General Counsel and Secretary | MOption exercise Common Stock | +7,583 | $56.94 | $432k | 18,540 | Nov 15, 2024 |
| Nov 14, 2024 | Mastrocola Lauren Principal Accounting Officer | SOpen-market sale Common Stock | -5,188 | $81.78 | $424k | 5,613 | Nov 15, 2024 |
| Nov 14, 2024 | Nemiroff Alex General Counsel and Secretary | SOpen-market sale Common Stock | -8,239 | $80.20 | $661k | 10,301 | Nov 15, 2024 |
| Nov 14, 2024 | Mastrocola Lauren Principal Accounting Officer | MOption exercise Stock Option (Right to Buy)derivative | -4,374 | $0.00 | $0 | 16,626 | Nov 15, 2024 |
| Nov 14, 2024 | Nemiroff Alex General Counsel and Secretary | MOption exercise Stock Option (Right to Buy)derivative | -7,583 | $0.00 | $0 | 28,817 | Nov 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Kelly Timothy EdwinChief Financial Officer
- Mastrocola LaurenPrincipal Accounting Officer
- Nemiroff AlexGeneral Counsel and Secretary
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.